Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b.
Jadoul
M
M
Department of Nephrology, Cliniques Universitaires St-Luc, University of Louvain Medical School, Brussels, Belgium.
Piessevaux
H
H
Ferrant
A
A
Cosyns
J P
JP
van Ypersele de Strihou
C
C
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000473:pathology; D000328:Adult; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply* / Q000473:pathology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000628:therapy*; D008297:Male; D008833:Microcirculation / Q000473:pathology; D008875:Middle Aged; D011994:Recombinant Proteins; D012078:Renal Artery Obstruction / Q000139:chemically induced / Q000473:pathology; D013927:Thrombosis / Q000139:chemically induced* / Q000150:complications* / Q000473:pathology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins